Telomere shortening in patients on long-term hemodialysis
- PMID: 34786545
- PMCID: PMC8579019
- DOI: 10.1016/j.cdtm.2021.07.003
Telomere shortening in patients on long-term hemodialysis
Abstract
Background: Leukocyte telomere length shortening is a characteristic of premature senescence, a process that can be accelerated by oxidative stress. In general, patients with end-stage renal disease undergoing regular hemodialysis (HD) are repeatedly exposed to oxidative stress. Patients undergoing HD tend to have cardiovascular diseases associated with oxidative stress and inflammation. Therefore, we assumed that telomere length is associated with HD vintage and the degree of vascular calcification.
Methods: A total of 144 patients undergoing regular HD before kidney transplantation and 62 patients on hemodialysis, but not undergoing kidney transplantation, were enrolled. We measured common laboratory values, such as calcium, phosphate, and hemoglobin levels, and assessed the degree of vascular calcification in the patients. The leukocyte telomere length was measured using reverse transcription polymerase chain reaction, and Spearman correlation was used for correlation analysis.
Results: The leukocyte telomere length was negatively associated with age (rho = -0.306, P<0.01); it was shorter in middle-aged patients than in young patients (13.48 ± 4.80 vs. 15.86 ± 4.51, P < 0.01). The telomere length was significantly different among patients aged 52-74 years in groups with different HD vintages. Additionally, the telomere length was positively associated with serum hemoglobin (Hb) levels in all patients (rho = 0.290, P < 0.01). There was a significant difference among patients divided into three groups according to the degree of anemia (17.09 ± 5.64 vs. 14.40 ± 4.07 vs. 13.99 ± 3.95, P < 0.01). Further, a significant difference was observed in the telomere length among patients with different degrees of vascular calcification (16.79 ± 4.91 vs. 13.61 ± 2.82 vs. 14.62 ± 3.63 vs. 10.71 ± 3.74, P < 0.01). The telomere length was shorter in the patients on hemodialysis who did not receive a kidney transplant than in the surgical patients (8.12 ± 1.83 vs. 14.33 ± 4.63, P < 0.01).
Conclusion: This study demonstrated that the telomere length was significantly correlated with HD vintage in patients of a certain age group. The telomere length was shorter in patients on hemodialysis who matched for age and dialysis vintage with kidney transplant patients. It was also associated with vascular calcification and serum Hb levels in all patients undergoing HD.
Keywords: Cardiovascular disease; Chronic kidney disease; Hemodialysis; Hemoglobin; Telomere length.
© 2021 Chinese Medical Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
Conflict of interest statement
None.
Figures




Similar articles
-
Telomere Length in Peripheral Blood Mononuclear Cells of Patients on Chronic Hemodialysis Is Related With Telomerase Activity and Treatment Duration.Artif Organs. 2015 Sep;39(9):756-64. doi: 10.1111/aor.12453. Epub 2015 Apr 20. Artif Organs. 2015. PMID: 25894013
-
Telomere Length Is Associated with Increased Risk of Cardiovascular Events in Patients with End-Stage Kidney Disease on Hemodialysis.Cardiorenal Med. 2024;14(1):524-532. doi: 10.1159/000541112. Epub 2024 Sep 9. Cardiorenal Med. 2024. PMID: 39250900
-
Lower Serum Irisin Levels Are Associated with Increased Vascular Calcification in Hemodialysis Patients.Kidney Blood Press Res. 2018;43(1):287-295. doi: 10.1159/000487689. Epub 2018 Feb 22. Kidney Blood Press Res. 2018. PMID: 29490308
-
High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity.PLoS One. 2016 Apr 11;11(4):e0151508. doi: 10.1371/journal.pone.0151508. eCollection 2016. PLoS One. 2016. PMID: 27064679 Free PMC article. Clinical Trial.
-
Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.Am J Kidney Dis. 2016 Nov;68(5S1):S24-S32. doi: 10.1053/j.ajkd.2016.05.024. Am J Kidney Dis. 2016. PMID: 27772640 Review.
Cited by
-
Telomere Attrition in Chronic Kidney Diseases.Antioxidants (Basel). 2023 Feb 25;12(3):579. doi: 10.3390/antiox12030579. Antioxidants (Basel). 2023. PMID: 36978826 Free PMC article. Review.
-
Association Between Telomere Shortening and Erythropoietin Resistance in Patients with Chronic Kidney Disease Undergoing Hemodialysis.Int J Mol Sci. 2025 Apr 5;26(7):3405. doi: 10.3390/ijms26073405. Int J Mol Sci. 2025. PMID: 40244253 Free PMC article.
-
Longer Telomere Length in Patients with Balkan Endemic Nephropathy Undergoing Chronic Hemodialysis Is Associated with Lower Cardiovascular Mortality.Kidney360. 2024 Dec 1;5(12):1871-1880. doi: 10.34067/KID.0000000603. Epub 2024 Oct 2. Kidney360. 2024. PMID: 39356569 Free PMC article.
-
COVID-19 increases mortality in hemodialysis patients: exploring links with inflammation and telomere attrition.Mol Biol Rep. 2024 Aug 27;51(1):938. doi: 10.1007/s11033-024-09879-7. Mol Biol Rep. 2024. PMID: 39190187
-
The influence of Klotho protein and prooxidant-antioxidant balance combination on the mortality of HD patients.Int Urol Nephrol. 2024 Feb;56(2):615-623. doi: 10.1007/s11255-023-03696-w. Epub 2023 Jul 6. Int Urol Nephrol. 2024. PMID: 37410303
References
-
- Smith D.H., Gullion C.M., Nichols G., Keith D.S., Brown J.B. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol. 2004;15:1300–1306. doi: 10.1097/01.asn.0000125670.64996.bb. - DOI - PubMed
LinkOut - more resources
Full Text Sources